Skip to Content

Programs & Resources

Phase 2 N01 Program

The Phase 2 N01 Program is a CTEP-CIP collaboration includes 7 contractors, most of whom consist of multi-institutional consortia, and includes a total of 22 NCI-designated Cancer Centers. These sites carry out early clinical trials with CTEP and CIP-held IND agents, with an emphasis on phase 2 trials, but including phase 1 trials as well. These trials include the evaluation of novel imaging agents and methods to enhance the evaluation of novel therapeutics.

For more information on the Phase 2 N01 Program and the list of approved contractors under this program, please see the CTEP Initiatives page at http://ctep.cancer.gov/industryCollaborations/default.htm#initiatives.